SCHEMBL812088

SCHEMBL812088

CC1CCC(C(C)C)CC1=O

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
KMT2A Q03164 1/20 0.37
PIK3CD O00329 1/20 0.31
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20608621 1.00 CA1 (0.38) CA1CA2CA4KMT2APIK3CD
SCHEMBL16253822 0.79 NOS3 (0.31) CA1CA2CA4NOS3NOS1
SCHEMBL23817259 0.78 CA1 (0.32) CA1CA2CA4KMT2APIK3CD
SCHEMBL17065221 0.78 CA1 (0.32) CA1CA2CA4KMT2APIK3CD
SCHEMBL19419764 0.77 TLR4 (0.39) NOS3NOS1NOS2
SCHEMBL2551618 0.75 CA1 (0.42) CA1CA2CA4KMT2A
SCHEMBL24336975 0.72
SCHEMBL24336976 0.72
SCHEMBL24316169 0.70
SCHEMBL19624810 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 EP claimed
EP-4025675-B1 A PERFUME OIL MIXTURE SYMRISE AG (DE) 2026-03-18 EP claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
US-12458918-B2 Process and apparatus for treating methane-containing gas KANADEVIA INOVA AG (CH) 2025-11-04 US claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
US-12421474-B2 Perfume oil mixture SYMRISE AG (DE) 2025-09-23 US claimed
US-20250262588-A1 PROCESS AND APPARATUS FOR TREATING METHANE-CONTAINING GAS KANADEVIA INOVA AG (CH) 2025-08-21 US claimed
EP-4536380-A1 PROCESS AND APPARATUS FOR TREATING METHANE-CONTAINING GAS Kanadevia Inova AG (CH) 2025-04-16 EP claimed
EP-4525822-A1 ANTIMICROBIAL MIXTURES Symrise AG (DE) 2025-03-26 EP claimed
CN-119306662-A Method for constructing molten pyridine compound by copper-catalyzed [2+1+3] cyclization reaction of cyclic ketone with alpha, beta-unsaturated aldehyde/ketone and ammonium iodide 湖南大学 2025-01-14 CN claimed
US-9021738-B2 Control of termites, fire ants and carpenter ants BEDOUKIAN RESEARCH, INC. (US) 2015-05-05 US claimed
US-20110213038-A1 CONTROL OF BED BUGS BEDOUKIAN ROBERT H 2011-09-01 US claimed
US-20110203160-A1 CONTROL OF TERMITES, FIRE ANTS AND CARPENTER ANTS BEDOUKIAN RESEARCH, INC. 2011-08-25 US claimed
WO-2010062368-A1 CONTROL OF TERMITES, FIRE ANTS AND CARPENTER ANTS BEDOUKIAN RESEARCH, INC. (US) 2010-06-03 WO claimed
WO-2010051027-A1 CONTROL OF BED BUGS BEDOUKIAN RESEARCH, INC. (US) 2010-05-06 WO claimed
CN-101370381-A Spatial inhibitors, deterrents and repellents for mosquitoes and midges BEDOUKIAN RES INC (US) 2009-02-18 CN claimed
EP-1919283-A4 SPATIAL INHIBITORS, DETERRENTS AND REPELLENTS FOR MOSQUITOES AND MIDGES BEDOUKIAN RESEACH INC (US) 2008-11-26 EP claimed
EP-1919283-A2 SPATIAL INHIBITORS, DETERRENTS AND REPELLENTS FOR MOSQUITOES AND MIDGES Bedoukian Reseach Inc. (US) 2008-05-14 EP claimed
WO-2007025197-A2 SPATIAL INHIBITORS, DETERRENTS AND REPELLENTS FOR MOSQUITOES AND MIDGES BEDOUKIAN RESEARCH, INC. (US) 2007-03-01 WO claimed
US-20070049644-A1 Spatial inhibitors, deterrents and repellents for mosquitoes and midges BEDOUKIAN RESEARCH, INC. 2007-03-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 CA1 4319/4885CA2 3362/4885CA4 3142/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 CA1 4061/4885CA2 3302/4885CA4 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.